The record first. Published August 6, 2020, US20200249101A1, "Thermal sensor package for earbuds" (CPC including A61B 5/01 and A61B 5/6817). This is a published application, not a grant. It describes packaging a thermal sensor against the ear canal — a site that gives a clean core-temperature read, which is why the ear is attractive real estate for health sensing.
Zoom out to the long bet. The wrist-worn wearable already carries heart-rate and oximetry sensing; the open question for the industry is where the next sensing surface lives. Earbuds are worn often, sit against a vascular-rich, temperature-stable site, and already have power and a radio. A thermal-sensor publication is an early, datable marker that some player is fencing the in-ear health opportunity before it is a shipping feature.
The business framing is about franchise extension, not a quarter. Health sensing is what lets a device maker argue its wearable is a medical-adjacent platform rather than an accessory — a story that supports premium pricing and, eventually, services attach. An in-ear sensor patent is an option on that extension, priced in R&D today against an undisclosed future line.
Comparability discipline applies. "Health sensing" spans heart rate, oximetry, temperature, and glucose, each with different regulatory and accuracy hurdles. The publication pins this claim narrowly to thermal sensing in the ear — useful for mapping who is staking which sensing modality, and a reminder that a publication is a position, not a product.
What the document does not disclose is the economics or even certainty of grant. It will not tell you accuracy, regulatory posture, or revenue. It establishes intent to fence in-ear thermal sensing; everything downstream is undisclosed.
For investors, the throughline is this: the wearables franchise grows by adding sensing surfaces, and the patent record is the earliest place you see which surface a player is betting on next. An earbud thermal-sensor publication is exactly that kind of early tell.